Category: Science


Unchartered Territory: When Should Patients Stop Immunotherapy?

By Cody R. Barnett, MRA Director of Communications | 23 January 2019 In Melanoma Stories, Science, Treatment

For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? In the absence of definitive data – what does indirect data tell us?

Read More


Melanoma Treatment Advances – 2018 in Review

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 18 January 2019 In Science, Treatment

2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.

Read More


MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

By Cody R. Barnett, MRA Director of Communications | 28 November 2018 In News, Science, Treatment

MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.

Read More


Dr. Marc Hurlbert Joins MRA as Chief Science Officer

By Cody R. Barnett, MRA Director of Communications | 20 November 2018 In Science

Dr. Marc Hurlbert has built his career advancing medical research in support of patients. Now, as of this month, he will translate his skills, relationships, and enthusiasm to achieving our mission of ending death and suffering due to melanoma as MRA’s Chief Science Officer.

Read More


When Astrophysics & Melanoma Collide

By Cody R. Barnett, MRA Director of Communications | 16 November 2018 In Science

Using lessons, processes, and tools from the field of astrophysics, Dr. Taube is studying melanoma in all new ways.

Read More


Improving the Lives of Melanoma Survivors

By Cody R. Barnett, MRA Director of Communications | 15 October 2018 In Prevention, Science

Melanoma survivors are at a 9-fold increased risk of developing another melanoma. Unfortunately, 20% of survivors reported a sunburn in the past year and 10% intentionally went outside for a tan – both strong predictors of inappropriate sun exposure.

Read More


Older Patients Do Better on Immunotherapy

By Cody R. Barnett, MRA Director of Communications | 8 October 2018 In Science, Treatment

In Dr. Weeraratna's study, older patients did better on immunotherapy than younger patients. This surprising result is the opposite of what was expected.

Read More


Using Zebrafish to Shed New Light on Melanoma

By Cody R. Barnett, MRA Director of Communications | 29 August 2018 In Science

Dr. Liz Patton, a MRA-funded cancer researcher at the Medical Research Council Human Genetics Unit at the University of Edinburgh, is fascinated by learning how things work. Patton has focused her research on better understanding how melanocytes – the cells in our skin that provide us our coloring – develop, divide, migrate, and in some unfortunate circumstances, proliferate uncontrollably turning into melanoma. Her work is providing critical insight into the origin of melanoma and what spurs melanoma to spread throughout the body.

Read More


Maintaining the Pace of Melanoma Innovation in the Era of an Evolving Standard of Care

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 August 2018 In Science, Treatment

There is no doubt that treatments for metastatic melanoma have changed dramatically in the decade since MRA’s founding in 2007. How do we keep up the momentum?

Read More


Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC

By Cody R. Barnett, MRA Director of Communications | 18 July 2018 In Allies & Partnerships, Melanoma Stories, News, Science, Treatment

When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.

Read More


Login

×